Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. The power of your gut
  3. (Super) bacterium may help better predict effectiveness of lung cancer treatment
  • Learn all about microbiota
    • The gut microbiota
    • The ENT microbiota
    • The pulmonary microbiota
    • The urinary microbiota
    • The skin microbiota
    • The vaginal microbiota
  • Microbiota and related conditions
    • Digestive disorders
    • Women disorders
    • Metabolic disorders
    • Skin disorders
    • Pediatric disorders
    • Psychiatric disorders
    • Neurological disorders
    • Respiratory disorders
    • Urinary disorders
  • Act on your microbiota
    • Probiotics
    • Prebiotics
    • Fecal Microbiota Transplant
    • Diet
  • Publications
    • Thematics folders
    • News
    • Press room
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Healthcare professionals section

Find here your dedicated section
Biocodex logo
The power of your gut
My microbiota as a woman
Our marvelous microbiota

Breadcrumb

  1. Home
  2. The power of your gut
  3. (Super) bacterium may help better predict effectiveness of lung cancer treatment
The power of your gut

(Super) bacterium may help better predict effectiveness of lung cancer treatment

Cancer
The gut microbiota

Predicting the effectiveness of treatments for diseases such as cancer is no easy task. This may all change thanks to promising research on the bacterium Akkermansia muciniphila (Akk). Further details on this (very) beneficial bacterium below.

The power of your gut
My microbiota as a woman
Our marvelous microbiota
  • Learn all about microbiota
    • The gut microbiota
    • The ENT microbiota
    • The pulmonary microbiota
    • The urinary microbiota
    • The skin microbiota
    • The vaginal microbiota
  • Microbiota and related conditions
    • Digestive disorders
    • Women disorders
    • Metabolic disorders
    • Skin disorders
    • Pediatric disorders
    • Psychiatric disorders
    • Neurological disorders
    • Respiratory disorders
    • Urinary disorders
  • Act on your microbiota
    • Probiotics
    • Prebiotics
    • Fecal Microbiota Transplant
    • Diet
  • Publications
    • Thematics folders
    • News
    • Press room
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Healthcare professionals section

Find here your dedicated section
Biocodex logo

Sources

This article is based on scientific information

Sharing is caring

Your friends might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • Mail

About this article

Created 24 May 2022
Updated 01 June 2022

Immunotherapy is now a common treatment for non-small-cell lung cancer (NSCLC). However, only 35% of patients experience long-term benefits from this treatment. Identifying biomarkers of response to immunotherapy may thus improve patients’ chances of survival.

Akkermansia muciniphila under the spotlight

Researchers at the Gustave Roussy Cancer Institute in France had already shown that the presence of Akkermansia in the gut microbiota was associated with clinical benefits in patients treated with immunotherapy.

The work of Lisa Derosa’s team, the results of which were published in prestigious medical journal Nature Medicine in 2022, goes one step further. The team investigated Akkermansia’s potential as a predictive marker of survival and response to immunotherapy among NSCLC patients.

They monitored 338 patients undergoing immunotherapy for four years :

  • 131 had Akkermansia in their gut flora (Akk+)
  • and 207 did not (Akk-). Their conclusions are very promising.

The gut microbiota

Find out more

Better patient survival 

The first finding was that patients with Akkermansia in their microbiota responded better to treatment: the Akk+ group had an overall survival of 18.8 months, compared to 15.4 months for the Akk- group. 

Another finding was that, unlike the Akk- group, the Akk+ patients had greater microbial diversity in their microbiota, which included bacteria with recognized beneficial effects on health and immune status, such as bifidobacteria, Faecalibacterium prausnitzii and Eubacterium hallii. 

Unsurprisingly, antibiotic use had an adverse effect on overall survival for both the Akk+ and Akk- groups, confirming the link between the use of antibiotics and a poor clinical outcome.

Akkermansia is therefore of major interest. The bacterium may offer a new therapeutic approach targeting the microbiota, thus giving hope to NSCLC patients.
To be continued.

Sources

Derosa L, Routy B, Thomas AM, et al. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nat Med. 2022 Feb;28(2):315-324.

Tags
Immunotherapy Lung cancer Akkermansia muciniphila

en_view en_sources

    See also

    Actu PRO un lien etabli entre microbiote intestinal et infections respiratoires The role of intestinal microbiota in respiratory infections
    COPD: gut microbiota in the dock
    Created 24 May 2022
    Updated 01 June 2022

    About this article

    To know more about this topic.

    Main topic

    Cancer

    Related microbiotas

    The gut microbiota
    The power of your gut

    Microbiota and Autism spectrum disorders

    Microbiota disruptions in the first years of life, when our intestinal flora and brain are developing, can ...

    Find out more

    Metabolic syndrome

    Metabolic syndrome represents a collection of metabolic problems associated with obesity, such as hypertrig...

    Find out more

    Digestive disorders

    Find out more

    Functional gastrointestinal disorders

    Functional gastrointestinal disorders (FGDs), the most common intestinal afflictions, are a collection of c...

    Find out more

    Infantile colic

    “My newborn baby’s cry is the most heartbreaking sound I’ve ever heard”.1 So confess many parents who turn ...

    Find out more

    Probiotics

    Probiotics: essential information for understanding and choosing them correctly. What exactly are probiotic...

    Find out more

    Pediatric disorders

    Find out more

    The gut microbiota

    Gut microbiota: why is it that important for your health? We have trillions1 of bacteria that populate our ...

    Find out more

    Latest news

    News
    Cancer du pancréas : bientôt un diagnostic précoce via le microbiote fécal ?
    24.06.2022

    Pancreatic cancer: soon an early diagnosis via the fecal microbiota?

    Read the article
    09.05.2022

    Is it normal that antibiotics give my child diarrhea?

    Read the article
    Un régime méditerranéen, bon pour le corps, bon pour le cœur
    16.06.2022

    The Mediterranean diet: good for the body, good for the heart

    Read the article
    16.05.2022

    Gut microbiota: still many things to be discovered

    Read the article
    16.05.2022

    What is your best advice for aging well?

    Read the article
    13.05.2022

    What is putting me in such a good mood today?

    Read the article
    02.03.2021

    Asthma: breathing in some fresh air on the farm!

    Read the article
    Anorexie : la piste du microbiote intestinal ?
    03.06.2022

    Anorexia: the gut microbiota pathway?

    Read the article
    My health, my microbiota
    Follow our Facebook page
    Our marvelous microbiota
    Get to understand our microbiota and the role they play in our body
    Find your dedicated section
    Healthcare professionals
    • Learn all about microbiota
      • The gut microbiota
      • The ENT microbiota
      • The pulmonary microbiota
      • The urinary microbiota
      • The skin microbiota
      • The vaginal microbiota
    • Microbiota and related conditions
      • Digestive disorders
      • Women disorders
      • Metabolic disorders
      • Skin disorders
      • Pediatric disorders
      • Psychiatric disorders
      • Neurological disorders
      • Respiratory disorders
      • Urinary disorders
    • Act on your microbiota
      • Probiotics
      • Prebiotics
      • Fecal Microbiota Transplant
      • Diet
    • Publications
      • Thematics folders
      • News
      • Press room
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Healthcare professionals section

    Find here your dedicated section
    Biocodex logo
    The power of your gut
    My microbiota as a woman
    Our marvelous microbiota
    • English
    • Français
    • Español
    • Portuguese
    • Polish

    Browse the site

    • Learn all about microbiota
      • The gut microbiota
      • The ENT microbiota
      • The pulmonary microbiota
      • The urinary microbiota
      • The skin microbiota
      • The vaginal microbiota
    • Microbiota and related conditions
      • Digestive disorders
      • Women disorders
      • Metabolic disorders
      • Skin disorders
      • Pediatric disorders
      • Psychiatric disorders
      • Neurological disorders
      • Respiratory disorders
      • Urinary disorders
    • Act on your microbiota
      • Probiotics
      • Prebiotics
      • Fecal Microbiota Transplant
      • Diet
    • Publications
      • Thematics folders
      • News
      • Press room
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Healthcare professionals section

    Find here your dedicated section
    Biocodex logo

    Discover

    The power of your gut
    My microbiota as a woman
    Our marvelous microbiota

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    Healthcare professionals section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the microbiota community and receive "The Essentials" once a month to stay up to date with the latest news on the microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    Cancer du pancréas : bientôt un diagnostic précoce via le microbiote fécal ?
    24.06.2022

    Pancreatic cancer: soon an early diagnosis via the fecal microbiota?

    Read the article
    Un régime méditerranéen, bon pour le corps, bon pour le cœur
    16.06.2022

    The Mediterranean diet: good for the body, good for the heart

    Read the article

    Urinary disorders

    Find out more

    Stay updated

    Join the Microbiota Community and receive once a month “The Essential” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Learn all about microbiota
      • The gut microbiota
      • The ENT microbiota
      • The pulmonary microbiota
      • The urinary microbiota
      • The skin microbiota
      • The vaginal microbiota
    • Microbiota and related conditions
      • Digestive disorders
      • Women disorders
      • Metabolic disorders
      • Skin disorders
      • Pediatric disorders
      • Psychiatric disorders
      • Neurological disorders
      • Respiratory disorders
      • Urinary disorders
    • Act on your microbiota
      • Probiotics
      • Prebiotics
      • Fecal Microbiota Transplant
      • Diet
    • Publications
      • Thematics folders
      • News
      • Press room
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Healthcare professionals section

    Find here your dedicated section
    Biocodex logo

    Discover

    The power of your gut
    My microbiota as a woman
    Our marvelous microbiota

    Healthcare professionals section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo